Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa

被引:6
|
作者
South, Andrew P. [1 ,11 ]
Laimer, Martin [2 ,3 ]
Gueye, Mouhamed [4 ]
Sui, Jennifer Y. [5 ,6 ]
Eichenfield, Lawrence F. [5 ,6 ]
Mellerio, Jemima E. [7 ]
Nystrom, Alexander [8 ,9 ,10 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[2] Paracelsus Med Univ, Univ Hosp, Dept Dermatol & Allergol, Salzburg, Austria
[3] Univ Hosp, Paracelsus Med Univ, EB House Austria, Salzburg, Austria
[4] Krystal Biotech, Pittsburgh, PA USA
[5] Univ Calif San Diego, Dept Dermatol, Sch Med, San Diego, CA USA
[6] Univ Calif San Diego Sch Med, Dept Pediat, San Diego, CA USA
[7] Rady Childrens Hosp San Diego, Div Pediat Dermatol, San Diego, CA USA
[8] Guys & St Thomas NHS Fdn trust, St Johns Inst Dermatol, London, England
[9] Univ Freiburg, Med Fac, Med Ctr, Dept Dermatol, Freiburg, Germany
[10] Freiburg Inst Adv Studies, Freiburg, Germany
[11] Thomas Jefferson Univ, Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, 233 S 10th St 406 BLSB, Philadelphia, PA 19107 USA
关键词
FIBROBLAST-GROWTH-FACTOR; NATIONAL-EB-REGISTRY; TGF-BETA; SKIN-CANCER; T-CELLS; PROGRESSION; PREVALENCE; MECHANISMS; EXPERIENCE; MUTATIONS;
D O I
10.1016/j.jid.2023.05.024
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Dystrophic epidermolysis bullosa is a rare genetic skin disorder caused by COL7A1 sequence variations that result in type VII collagen deficits and cutaneous and extracutaneous manifestations. One serious complication of dystrophic epidermolysis bullosa is cutaneous squamous cell carcinoma, a leading driver of morbidity and mortality, especially among patients with recessive dystrophic epidermolysis bullosa. Type VII collagen deficits alter TGFb signaling and evoke multiple other cutaneous squamous cell carcinoma progression-promoting activities within epidermal microenvironments. This review examines cutaneous squamous cell carcinoma pathophysiology in dystrophic epidermolysis bullosa with a focus on known oncogenesis pathways at play and explores the idea reduce cutaneous squamous cell carcinoma risk.
引用
收藏
页码:2108 / 2119
页数:12
相关论文
共 50 条
  • [21] Glycine substitutions in type VII collagen responsible for dystrophic epidermolysis bullosa.
    Gilgenkrantz, S
    M S-MEDECINE SCIENCES, 1996, 12 (8-9): : 1007 - 1008
  • [22] In vivo restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa
    Chen, M
    Chan, L
    Hoeffler, EK
    Finlay, D
    Keene, DR
    Woodley, DT
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 228 - 228
  • [23] Mini-type VII collagen corrects murine dystrophic epidermolysis bullosa
    Woodley, D.
    Wang, X.
    Remington, J.
    Burnett, J.
    Kim, G.
    Chen, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S92 - S92
  • [24] Mini-type VII collagen corrects dystrophic epidermolysis bullosa mouse
    Remington, J. M.
    Wang, X.
    Woodley, D. T.
    Chen, M.
    Guan, S.
    Li, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S77 - S77
  • [25] DOMINANT DYSTROPHIC EPIDERMOLYSIS-BULLOSA WITH INTRAEPIDERMAL TYPE-VII COLLAGEN
    MCCOLLOUGH, ML
    GRIMWOOD, RE
    GRABSKI, WJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (03) : 512 - 512
  • [26] SQUAMOUS-CELL CARCINOMA AS A COMPLICATION OF DYSTROPHIC EPIDERMOLYSIS BULLOSA
    TIDMAN, MJ
    ATHERTON, DJ
    EADY, RAJ
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1984, 77 : 37 - 39
  • [27] Recombinant type VII collagen significantly increases transwell migration in squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa
    Pourreyron, C.
    Hogan, C.
    Cole, C. L.
    Bruckner-Tuderman, L.
    McGrath, J. A.
    Leigh, I. M.
    South, A. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (04) : 925 - 925
  • [28] Does the presence or absence of type VII collagen expression in individuals with recessive dystrophic epidermolysis bullosa have implications for the risk of developing squamous cell carcinoma?
    Cox, G. A.
    Pourreyron, C.
    Volz, A.
    O'Toole, E. A.
    Chen, M.
    Bruckner-Tuderman, L.
    Salas-Alanis, J. C.
    Leigh, I. M.
    South, A. P.
    McGrath, J. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 : 12 - 13
  • [29] Patients with recessive dystrophic epidermolysis bullosa develop squamous cell carcinoma regardless of type VII collagen NC1 domain expression.
    Pourreyron, C.
    Jones, C.
    Volz, A.
    O'Toole, E. A.
    Chen, M.
    Hart, I. R.
    Bruckner-Tuderman, L.
    Salis-Alanis, J. C.
    McGrath, J. A.
    Leigh, I. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 32 - 32
  • [30] SLCO1B3 expression in recessive dystrophic epidermolysis bullosa associated squamous cell carcinoma is reduced by recombinant type VII collagen
    Cole, C. L.
    Pourreyron, C.
    Foerster, J.
    Purdie, K.
    Salas-Alanis, J. C.
    Murrell, D. F.
    Bruckner-Tuderman, L.
    McGrath, J. A.
    Leigh, I. M.
    South, A. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S55 - S55